Microbot Medical Inc.
NASDAQ:MBOTMedical - Instruments & Supplies
-$0.06 today
- Market cap
- $65.73M
- Beta
- 1.04
- P/E (TTM)
- -8.6
- EPS (TTM)
- -$0.21
Volume 0.87M
Average 1.60M
MBOT Total Liabilities
Everything the company owes to creditors and other parties.
Microbot Medical Inc.NASDAQ: MBOT
Total Liabilities · Q1 FY2026 · quarter ended Mar 2026
Total liabilities rises 104.1% from a year ago
Total liabilities stood at $3.96M at the end of Q1 FY2026, up 104.1% from a year earlier and down 0.7% from the prior quarter. Over 3 fiscal years it compounded at +21.1% a year.
Context
- Total liabilities amounted to 5.1% of total assets at the end of Q1 FY2026, down 1.2 pp from a year earlier.
- Total liabilities increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total liabilities keeps rising in the next quarterly balance sheet after a +104.1% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 3.99M USD
- Year-over-year change
- +59.5%
- 4-year CAGR
- +13.7%
| Period | Period end | Total Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 3.99M | +59.5% |
| FY2024 | 2024-12-31 | 2.5M | -34.6% |
| FY2023 | 2023-12-31 | 3.83M | +70.2% |
| FY2022 | 2022-12-31 | 2.25M | -5.8% |
| FY2021 | 2021-12-31 | 2.39M | — |
Total Liabilities vs competitors
How MBOT compares with its peers on the latest reported figures
- Peers report in different currencies, so total liabilities is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +104.1% is the 3rd highest of 10, against a peer median of +22.3%.
- Total liabilities amounts to 5.1% of total assets for MBOT, versus a peer median of 35.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $98.02M USD | -23.9% | -7.3% | 46.8% | |
| Mar 2026 | $74.71M USD | +0.8% | +75.5% | 144.9% | |
| Mar 2026 | $40.47M USD | +33.6% | -4.7% | 186.8% | |
| Mar 2026 | $30.57M USD | +299.9% | +43.7% | 11.4% | |
| Mar 2026 | $27.36M USD | +22.3% | -4.1% | 12.1% | |
| Mar 2026 | $23.27M USD | -2.4% | +51.4% | 54.9% | |
| Mar 2026 | CA$7.22M CAD | -8.2% | -7.5% | 22.9% | |
| Mar 2026 | $6.66M USD | +235.7% | +35.7% | 11.3% | |
| Mar 2026 | CA$5.3M CAD | +45.3% | +22.2% | 35.0% | |
| Mar 2026 | $3.96M USD | +104.1% | +21.1% | 5.1% | |
| Peer median (excluding MBOT) | — | +22.3% | +22.2% | 35.0% | |
Competitors are the stored peer set for MBOT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Microbot Medical Inc.
NASDAQ:MBOT
Intrinsic Alpha fair value
Locked
Current Price
$0.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.